These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10904873)

  • 1. The signaling pathway of cardiotrophin-1 is not activated in hypertrophied ventricles of carnitine-deficient juvenile visceral steatosis (JVS) mice.
    Yoshida G; Horiuchi M; Kobayashi K; Jalil MD; Iijima M; Hagihara S; Nagao N; Saheki T
    In Vivo; 2000; 14(3):401-5. PubMed ID: 10904873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered expression of atrial natriuretic peptide and contractile protein genes in hypertrophied ventricle of JVS mice with systemic carnitine deficiency.
    Yoshimine K; Horiuchi M; Suzuki S; Kobayashi K; Abdul JM; Masuda M; Tomomura M; Ogawa Y; Itoh H; Nakao K; Osame M; Saheki T
    J Mol Cell Cardiol; 1997 Feb; 29(2):571-8. PubMed ID: 9140816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of cardiac hypertrophy in carnitine-deficient juvenile visceral steatosis (JVS) mice achieved by lowering dietary lipid.
    Jalil MA; Horiuchi M; Wakamatsu M; Li MX; Begum L; Suzuki K; Kobayashi K; Oka T; Saheki T
    J Biochem; 2006 Feb; 139(2):263-70. PubMed ID: 16452314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catecholamine metabolism inhibitors and receptor blockades only partially suppress cardiac hypertrophy of juvenile visceral steatosis mice with systemic carnitine deficiency.
    Jalil A; Horiuchi M; Nomoto M; Kobayashi K; Saheki T
    Life Sci; 1999; 64(13):1137-44. PubMed ID: 10210276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of cardiac hypertrophy in the juvenile visceral steatosis mouse with systemic carnitine deficiency.
    Kuwajima M; Lu K; Sei M; Ono A; Hayashi M; Ishiguro K; Ozaki K; Hotta K; Okita K; Murakami T; Miyagawa J; Narama I; Nikaido H; Hayakawa J; Nakajima H; Namba M; Hanafusa T; Matsuzawa Y; Shima K
    J Mol Cell Cardiol; 1998 Apr; 30(4):773-81. PubMed ID: 9602426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyruvate dehydrogenase kinase 4 mRNA is increased in the hypertrophied ventricles of carnitine-deficient juvenile visceral steatosis (JVS) mice.
    Horiuchi M; Kobayashi K; Masuda M; Terazono H; Saheki T
    Biofactors; 1999; 10(2-3):301-9. PubMed ID: 10609898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressed expression of the urea cycle enzyme genes in the liver of carnitine-deficient juvenile visceral steatosis (JVS) mice in infancy and during starvation in adulthood.
    Tomomura M; Tomomura A; Musa DA; Horiuchi M; Takiguchi M; Mori M; Saheki T
    J Biochem; 1997 Jan; 121(1):172-7. PubMed ID: 9058209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel mRNA molecules are induced in hypertrophied ventricles of carnitine-deficient mice and belong to a family of up-regulated gene in cells overexpressing c-erbB-2.
    Fukumaru S; Horiuchi M; Kobayashi K; Jalil MA; Iijima M; Masuda M; Begum L; Higashi M; Wakana S; Kanzaki T; Saheki T
    Biochim Biophys Acta; 2002 Sep; 1577(3):437-44. PubMed ID: 12359334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel gene suppressed in the ventricle of carnitine-deficient juvenile visceral steatosis mice.
    Masuda M; Kobayashi K; Horiuchi M; Terazono H; Yoshimura N; Saheki T
    FEBS Lett; 1997 May; 408(2):221-4. PubMed ID: 9187371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II interferes with leukemia inhibitory factor-induced STAT3 activation in cardiac myocytes.
    Tone E; Kunisada K; Fujio Y; Matsui H; Negoro S; Oh H; Kishimoto T; Yamauchi-Takihara K
    Biochem Biophys Res Commun; 1998 Dec; 253(1):147-50. PubMed ID: 9875235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmented expression of cardiotrophin-1 in failing human hearts is accompanied by diminished glycoprotein 130 receptor protein abundance.
    Zolk O; Ng LL; O'Brien RJ; Weyand M; Eschenhagen T
    Circulation; 2002 Sep; 106(12):1442-6. PubMed ID: 12234945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac hypertrophy in juvenile visceral steatosis (jvs) mice with systemic carnitine deficiency.
    Horiuchi M; Yoshida H; Kobayashi K; Kuriwaki K; Yoshimine K; Tomomura M; Koizumi T; Nikaido H; Hayakawa J; Kuwajima M
    FEBS Lett; 1993 Jul; 326(1-3):267-71. PubMed ID: 8325377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidant changes in the hypertrophied heart due to energy metabolic disorder.
    Kamiya H; Okumura K; Ito M; Matsui H; Saburi Y; Hayashi K; Hayakawa T
    Basic Res Cardiol; 2001 Sep; 96(5):431-8. PubMed ID: 11605989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in distinct species of 1,2-diacylglycerol in cardiac hypertrophy due to energy metabolic disorder.
    Saburi Y; Okumura K; Matsui H; Hayashi K; Kamiya H; Takahashi R; Matsubara K; Ito M
    Cardiovasc Res; 2003 Jan; 57(1):92-100. PubMed ID: 12504818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary fish oil attenuates cardiac hypertrophy in lipotoxic cardiomyopathy due to systemic carnitine deficiency.
    Takahashi R; Okumura K; Asai T; Hirai T; Murakami H; Murakami R; Numaguchi Y; Matsui H; Ito M; Murohara T
    Cardiovasc Res; 2005 Nov; 68(2):213-23. PubMed ID: 15963478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of the feeding response to fasting in carnitine-deficient juvenile visceral steatosis (JVS) mice: involvement of defective acyl-ghrelin secretion and enhanced corticotropin-releasing factor signaling in the hypothalamus.
    Sakoguchi T; Horiuchi M; Asakawa A; Ushikai M; Yoshida G; Fujimiya M; Kato I; Nakazato M; Takeuchi T; Saheki T; Inui A
    Biochim Biophys Acta; 2009 Nov; 1792(11):1087-93. PubMed ID: 19744557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of PDK4 in the heart muscle of JVS mice, an animal model of systemic carnitine deficiency, does not appear to reduce glucose utilization by the heart.
    Ushikai M; Horiuchi M; Kobayashi K; Matuda S; Inui A; Takeuchi T; Saheki T
    Mol Genet Metab; 2011 Mar; 102(3):349-55. PubMed ID: 21190881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukemia inhibitory factor mRNA expression is upregulated in macrophages and olfactory receptor neurons after target ablation.
    Getchell TV; Shah DS; Partin JV; Subhedar NK; Getchell ML
    J Neurosci Res; 2002 Jan; 67(2):246-54. PubMed ID: 11782968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A heart-specific increase in cardiotrophin-1 gene expression precedes the establishment of ventricular hypertrophy in genetically hypertensive rats.
    Ishikawa M; Saito Y; Miyamoto Y; Harada M; Kuwahara K; Ogawa E; Nakagawa O; Hamanaka I; Kajiyama N; Takahashi N; Masuda I; Hashimoto T; Sakai O; Hosoya T; Nakao K
    J Hypertens; 1999 Jun; 17(6):807-16. PubMed ID: 10459879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. gp130-Dependent signalling pathway is not enhanced in gp130 transgenic heart after LIF stimulation.
    Tone E; Kunisada K; Kumanogoh A; Negoro S; Funamoto M; Osugi T; Kishimoto T; Yamauchi-Takihara K
    Cytokine; 2000 Oct; 12(10):1512-8. PubMed ID: 11023666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.